Target intelligence / Profile preview

Fenvalerate-degrading enzymes (Enterobacter spp. and Micrococcus spp.)

Molecular classification
Enzyme, Hydrolase, Esterase
01

Overview

Fenvalerate-degrading enzymes from Enterobacter and Micrococcus species are microbial proteins, primarily carboxylesterases and hydrolases, that facilitate the breakdown of the synthetic pyrethroid insecticide fenvalerate (PubChem CID 3323). These enzymes play a critical role in environmental bioremediation by detoxifying pesticide residues in soil and water systems (Chen et al., 2011, Journal of Hazardous Materials). The biological function involves the cleavage of the ester linkage within the fenvalerate structure, converting the parent compound into smaller, typically less harmful metabolites like 3-phenoxybenzoic acid (3-PBA) (Tallur et al., 2008, Biodegradation). While not a therapeutic target for human disease, these enzymes are significant in the context of environmental health and toxicology. They are studied for their potential to mitigate the ecological impact of pyrethroid contamination and to understand the metabolic pathways of xenobiotics in microbial consortia. The efficiency of these enzymes is often enhanced when Enterobacter and Micrococcus species work in syntrophic association, allowing for more complete mineralization of the pesticide.

Other names
Pyrethroid hydrolasesFenvalerate carboxylesterasesMicrobial pyrethroid-degrading enzymes
02

Mechanism of action

The enzymes catalyze the hydrolysis of the ester bond in the fenvalerate molecule, breaking it down into less toxic metabolites such as 3-phenoxybenzoic acid.

03

Biological functions

Xenobiotic metabolismBiodegradationPesticide detoxification
04

Disease associations

Environmental toxicityPesticide poisoning
05

Safety considerations

Accumulation of toxic metabolitesIncomplete degradationEnvironmental persistence of intermediates
06

Interacting drugs

Fenvalerate
07

Biomarkers

3-phenoxybenzoic acid (3-PBA)Alpha-isopropyl-4-chlorophenylacetic acid

Beyond the preview

Go deeper on Fenvalerate-degrading enzymes (Enterobacter spp. and Micrococcus spp.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fenvalerate-degrading enzymes (Enterobacter spp. and Micrococcus spp.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call